Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults.

Abstract

Acute lymphocytic leukemia remains a difficult disease to treat in adults. Allogeneic bone marrow transplantation can cure some patients with ALL, but GVHD transplant-related mortality and disease relapse remain problematic. Immunotherapeutic approaches aimed at eliminating minimal residual disease and enhancing the GVL effect may decrease relapse rates and improve overall survival. Because of the rarity of this disease in adults, every new patient should be entered in well-designed, peer-reviewed, investigational trial.

Statistics

0200400'03'05'07'09'11'13'15'17
Citations per Year

1,559 Citations

Semantic Scholar estimates that this publication has 1,559 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Martin2001AllogeneicSC, title={Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults.}, author={Thomas G. Martin and James L. Gajewski}, journal={Hematology/oncology clinics of North America}, year={2001}, volume={15 1}, pages={97-120} }